Elan, GlaxoSmithKline, Janssen, Johnson & Johnson, Lilly Research, Parke Davis, Robert Wood Johnson and Smith Kline Beecham
|
|
|
- Lewis Daniel
- 5 years ago
- Views:
Transcription
1 2 Kenneth Altshuler MD Center Dallas Janssen 3 4 Lori Altshuler MD UCLA Abbott Western Psychiatric Institute Boris Birmaher MD Pittsburg, PA Forest Eli Lilly, Forest, Janssen, AstraZeneca,, GlaxoSmithKline, Shire, Schering Plough, Jazz, Solvay AstraZeneca, Bristol Myers Squibb. Eli Lilly, GlaxoSmithKline 5 Charles Bowden MD Health Elan, GlaxoSmithKline, Janssen, Johnson & Johnson, Lilly Research, Parke Davis, Robert Wood Johnson and Smith Kline Beecham Abbott, GlaxoSmithKline, Janssen, Eli Lilly, Lilly Research, Sanofi Synthelabo, UCB Pharma, AstraZeneca, Abbott, AstraZeneca, Eli Lilly, GlaxoSmithKline, Janssen 6 7 Robert Buchanan MD University of Maryland Janssen, Ortho McNeil Myers Squibb, Eli Lilly, Janssen,, Solvay, Peter Buckley MD Medical College of Georgia Novartis AstraZeneca, GlaxoSmithKline, Merck, Organon,, Roche, Solvay, Myers Squibb, Eli Lilly, Janssen, Merck,, Alamo, Novartis Abbott, AZ, BMS, Eli Lilly, Janssen,, Alamo, AstraZeneca 8 Joseph Calabrese MD Case Western Reserve University, Cleveland Ohio Abbott, AstraZeneca, Merck, Eli Lilly,, Ciba Geigy, Robert Wood Johnson, Sandoz, Tap, UCB Pharma, Myers Squibb/Otsuka, Eli Lilly, Teva, Janssen, Robert Wood Johnson, Tap, UCB Pharma, Novartis, Parke Davis, Shire
2 9 Caryn Carlson PhD Austin John Chiles MD University of Washington, (Formerly) Univ Texas Health Janssen, Eli Lilly AstraZeneca, Janssen, Eli Lilly Ivax, Alkermes, Cortex Robert Conley MD (Formerly) University of Maryland (Currently) Eli Lilly AstraZeneca, Eli Lilly, Janssen,, Johnson & Johnson C Keith Conners PhD Duke University Novartis, Eli Lilly, McNeil, Shire, GlaxoSmithKline Squibb, Cyberonics, Eli Lilly, Forest, Janssen, McNeil,, Pharmacia, Shire, Corcept Therapeutics Lynn Crismon Univ of Texas College of PharmD Pharmacy Myers Squibb, Eli Lilly, Forest, Janssen,, Shire John Curry PhD Duke University Reach institute Ella Daly Center Dallas Adjunct prof. And Johnson & Johnson MB MRCemployee Charles DeBattista MD Stanford University Pedro Delgado MD Health GlaxoSmithKline,, Abbott, Eli Lilly,, Cephalon AstraZeneca, Corcept Therapeutics, Forest, Medtronics, Eli Lilly, GlaxoSmithKline, Organon,, Forest Corcept, GlaxoSmithKline,, Abbott, Eli Lilly,, Cephalon AstraZeneca, Eli Lilly, Forest, Neuronetics,, GlaxoSmithKline, Organon Corcept Eli Lilly,, Ayerst 8 Ellen Dennehy Phd Purdue University, (formerly) UTSWMC Dallas
3 9 20 Graham Emslie MD Center Dallas Eli Lilly, Organon, Forest New York Dept of Mental Susan Essock PhD Health Eli Lilly, GlaxoSmithKline, Forest,, Ayerst, Ortho McNeil Maurizio Fava MD Molly Finnerty MD Barbara Geller MD Lawrence L Greenhill MD Massachusetts General Hospital, Harvard New York Dept of Mental Health Washington University School of Medicine in St. Louis New York State Psychiatric Institute Abbott, Alkermes, Aspect Medical, AstraZeneca, Bristol Myers Squibb, Cephalon, Eli Lilly, Forest, GlaxoSmithLine, Johnson & Johnson, Lichtwer Pharma, Lorex, Novartis, Organon, pamlab,, Pharmcia & Upjohn, Pharmavite, Roche, Sanofi/Synthelabo, Sanofi Aventis, Spracor, Solvay, Ayerst Novartis, Eli Lilly, Aspect Medical, AstraZeneca, Bayer, Biovail, BrainCells, Cephalon, Compellis, Cypress Bioscience, Dov, Eli Lilly, EPIX, Janssen, Jazz, Johnson & johson, Knoll, Lundbeck, MedAvante, Neuronetics, Novartis, Nutrician2, Organon, PamLab,, Pharmacia & Upjohn, PharmaStar, Phamavite, Roche, Sanofi/Synthelabo, Sanofi Aventis, Spracor, Solvay, Somozon, Somerset, Ayerst. Solvay, Novartis, Eli Lilly, Celltech, Ortho McNeil, Janssen AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Cephalon, Compellis, Eli Lilly, MedAvante, Novartis, Organon,, PharmaStar, Ayerst
4 Robert Hirschfeld MD Carroll Hughes Phd Peter Jensen MD The Reach Institute David Kahn MD Columbia University Martin Keller MD Brown University Ayerst, Abbott, Squibb, Forest, Cephalon, Forest, Eli Ortho McNeil, Eli Lilly, Medical Branch Galveston Lilly, Novartis, Organon,, shire, UCB Pharma Novartis, Organon,, Shire, Solvay, Wyety Center Dallas GlaxoSmithKline Janssen Janssen, McNeil,, Eli Lilly, Novartis, Magellan Forest, Merck, Organon,, SmithKlineBeecham, Pharmacia Upjohn, Ayerst Janssen, UCB Pharma, Novartis, CMED, McNeil, Otsuka, Shire Eli Lilly,, Cypress, Cyberonics, Forest, Janssen, Organan,, Novartis, Cephalon, Merck,, Pharmacia Upjohn, Ayerst Eli Lilly 30 Terence Ketter MD Stanford University Myers Squibb, Elan, Eli Lilly, Novartis, Shire, Solvay, Myers Squibb, Cephalon, Corcept, Elan, Eli Lilly, Forest, Jazz, Merck, Novartis, Shire, Solvay,, UCB Pharma, Abbott, AstraZeneca, Eli Lilly, GlaxoSmithKline, Janssen, Novartis,, Shire 3 Robert Kowatch MD (Formerly) University of Texas Center. (Currently) Cincinnati Childrens Hospital Bristol Myers Squibb GlaxoSmithKline, Astrazeneca, Abbott
5 32 33 Scott and White Hospital and Clinic, Department of Maria Llana PharmD Psychiatry Molly Lopez Phd Lauren Marangell MD Stephen Marder MD James McCracken MD UCLA (Formerly) Baylor (Currently) Eli Lilly West Los Angeles VA Health Care Center, Calif Joseph McEvoy MD Duke University Alexander Miller MD Health Cyberonics, Eli Lilly, Neuronetics Aspect Medical, Cyberonics, Eli Lilly, Medtronics, Novartis, Eli Lilly, Organon, GlaxoSmithKline, Merck, AstraZeneca, Janssen, Bristol Otsuka,, Solvay, Janssen, Myers Squibb, Eli Lilly Shire, Eli Lilly, McNeil, Janssen, Eli Lilly, Shire, Bristol Myers Cephalon, Abbott, UCB Squibb Pharma. Squibb, Eli Lilly, Organon,, Sanofi Synthelabo Abbott, Almirall, Squibb, Eli Lilly, Janssen, GlaxoSmithKline; Eli Lilly, Myers Squibb, Eli Lilly, Janssen, Cyberonics, Eli Lilly, GlaxoSmithKline, Forest, Eli Lilly, Janssen, Otsuka Alexander Miller MD Del Miller Md Alexza, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Forest, Squibb, Centene, Dainippon Health GlaxoSmithKline, Janssen Research Foundation, Organon, Sumitomo, Eli Lilly, Janssen, Oraganon,, Solvay, InforMedix, Iowa Carver College of Medicine Eli Lilly Janssen AstraZeneca, Biovail, Eli Lilly, Janssen,
6 4 Troy Moore PharmD Health 42 Craig Nelson MD Yale University Eli Lilly, Janssen, Organon, Abbott, AstraZeneca, Biovail, Corcept, Eli Lilly, Forest, GlaxoSmithKline, Novartis, Orexigen, Organon,, Janssen, Shire, Andrew Nierenberg MD Glen Pearson MD Teresa Pigott MD Massachusetts General Hospital Center Medical Branch Galveston Squibb, Cederroth, Cyberonics, Eli Lilly, Forest, GlaxoSmithKline, Lichtwer, Millenium, Organon,, Eli Lilly, GlaxoSmithKline,, Forest Eli Lilly, Genaissance, GlaxoSmithKline, Jazz, Innapharma, Janssen Cilag, Neuronetics, Novartis, Organon,, Sepracor, Shire, Somerset, Sumitomo,, Cyberonics, Shire, Cederroth, Janssen Cyberonics, Eli Lilly, Organon, 46 Steven Pliszka MD Health Eli Lilly, Cephalon, AstraZeneca Shire, McNeil
7 47 48 Kelly Posner PhD Columbia University Albert Einstein College of Delbert Robinson MD Medicine, New York GlaxoSmithKline, Forest, Eisai, AstraZeneca, Johnson & Johnson, Abbott, Organon, Sanofi Aventis, Cephalon, Novartis, Shire, UCB Pharm Janssen 49 Anthony Rothschild MD University of Massachusetts Cephalon, Cyberonics, Novartis,, Eli Lilly, Bristol Myers Squibb Eli Lilly,, Abbott 50 John Rush MD (Formerly) University of Texas Center Dallas. (Currently) Duke University in Singapore Robert Wood Johnson Foundation AstraZeneca, Robert Wood Foundation, Bristol Myers Squibb, Cyberonics, Eli Lilly, Organon (Akzo),, Advanced Neuromodulation, Gerson Lehman, Guilford Publications, Healthcare Technology Systems, Jazz, Ono, Merck Cyberonics, Forest, GlaxoSmithKline, Merck, 5 Neal Ryan MD Western Psychiatric Institute Pittsburg, PA GlaxoSmithKline, GlaxoSmithKline, Bristol Myers Squibb, Abbott, Janssen 52 Gary Sachs MD Harvard Medical School Novartis,, Myers Squibb, Eli Lilly, Memory, Merck, Otsuka, Novartis, Elan, Sanofi, UCB Pharma,, Shire, Abbott, AstraZeneca, Eli Lilly, GlaxoSmithKline, Janssen,Otsuka,, Sanofi Aventis,
8 New York State Psychiatric Institute, Columbia MECTA, Neurocrine, Harold Sackeim Phd University Cyberonics, Magstim Dept of Veteran Affairs, Nina Schooler PhD Wash DC Andrew Sedillo MD Texas Dept of MHMR Squibb, Eli Lilly, Janssen, MECTA, Neurocrine, Cyberonics Eli Lilly, Forest, Janssen, Merck, Organon,, Vanda, Johnson & Johnson Abbott, AstraZeneca, Eli Lilly,, Sanofi Aventis, Janssen,, Abbott, Bristol Myers Squibb, Eli Lilly,, Solvay, Richard Shelton MD Vanderbilt University Texas Dept of State Health Steven Shon MD Services Janssen Texas Department of Mental Thomas Stidvent MD Health (Waco) Michael Strober PhD UCLA AstraZeneca Thomas Scott Stroup MD University of North Carolina Eli Lilly Eli Lilly, Janssen, 6 Trisha Suppes MD. PhDCenter Myers Squibb, Novartis, Robert Wood Johnson Foundation Myers Squibb, Eli Lilly, Johnson & Johnson, Novartis, Organon, Pharmaceutical Research Institute, Ortho McNeil, Shire, Solvay and UCB Pharma. AstraZeneca; GlaxoSmithKline 62 Alan Swann MD Health Science Center Houston CIBA, Eli Lilly, UCB, Shire, Novartis, Abbott, AstraZeneca, UCB, Shire, GlaxoSmithKline, Eli Lilly, Janssen, Novartis,, Ortho McNeil Abbott, Eli Lilly, Ortho McNeil, Parke Davis,
9 McNeil, Cephalon, UCB Pharma, Shire, CellTech, Novartis/Celgene, Eli Lilly, James Swanson Phd Sackler Institute, UCLA Abbott, Janssen Michael Thase MD Western Psychiatric Institute Pittsburg, PA Marcia Toprac MD TDMHMR Trello Kathy Rishel MD Center McNeil, Cephalon, UCB Pharma, Shire, Janssen Novartis/Celgene, Eli Lilly, Abbott, Celltech, Targacept Squibb, Cephalon, Cyberonics, Eli Lilly, Forest, Neuronetics, Novartis, Organon,, Sepracor, Shire, Shire Was full time worker for Celgene in 2005 AstraZeneca, Bristol Myers Squibb, Cyberonics, Eli Lilly, GlaxoSmithKline, Organon, Sanofi Aventis, Madhuker Trivedi MD Center Dallas Benedetto Vitiello MD NIMH Abbott, Organon, Bayer, Eli Lilly, Janssen, Johnson & Johnson, Parke Davis, Pharmacia & Upjohn, Solvay, Organon, Bristol Myers Squibb, Eli Lilly, Forest, Janssen, Pharmcia & Upjohn, Solvay, Karen Dineen Wagner MD Medical Branch Galvestorn Abbott, Eli Lilly, Forest, GlaxoSmithKline,, < organon AstraZeneca, Abbott, Bristol Myers Squibb, Otsuka, GlaxoSmithKline,, Eli Lilly, Forest, Janssen, Novartis, UCB Ortho McNeil The data presented reflects members of the TMAP consensus panels as named in published papers. The data presented in columns representing research/grants and/or Consultant/Speakers Bureau/Advisory Board members is derived from disclosures filed by each person or their institution in a publication publicly available, such as Disclosure Indexes from industry sypmposia.
Do the Right Thing: Good Clinical Practice for Clinical Research
Do the Right Thing: Good Clinical Practice for Clinical Research Andrew A. Nierenberg, MD Director, Bipolar Clinic and Research Program, Director, Training and Education, MGH Research Institute Massachusetts
Cognitive Impairment in Major Depressive Disorder as a Target for Drug Development
Cognitive Impairment in Major Depressive Disorder as a Target for Drug Development Maurizio Fava, MD Director Clinical Research Program Executive Vice Chair Department of Psychiatry Executive Director
Desktop Delivery Cover Sheet
InterLibrary Loan Article Delivery Service http://www.library.uthscsa.edu/illiad ariel-ill@uthscsa.edu Briscoe Library 7703 Floyd Curl Drive San Antonio, TX 78229 (210) 567-2460 (210) 567-2463 (fax) Desktop
Bipolar Depression Update 2016
Bipolar Depression Update 2016 Andrew A. Nierenberg, MD Thomas P. Hackett, MD, Endowed Chair in Psychiatry Director, Bipolar Clinic and Research Program Massachusetts General Hospital Professor of Psychiatry,
Bipolar Depression Update 2015
Bipolar Depression Update 2015 Andrew A. Nierenberg, MD Thomas P. Hackett, MD, Chair in Psychiatry Director, Bipolar Clinic and Research Program Massachusetts General Hospital Professor of Psychiatry,
Atoms, represents a relatively common depressive subtype.
Bupropion Versus SSRIs in Anxious Depression Efficacy of Bupropion and the Selective Serotonin Reuptake Inhibitors in the Treatment of Major Depressive Disorder With High Levels of Anxiety (Anxious Depression):
Stahl s Illustrated. Mood Stabilizers. Stephen M. Stahl. University of California at San Diego. Nancy Muntner. Illustrations. Sara Ball.
Stahl s Illustrated Mood Stabilizers University of California at San Diego Nancy Muntner Illustrations Sara Ball Editor c a m b r i d g e university pr e s s Cambridge, New York, Melbourne, Madrid, Cape
Stahl s Illustrated. Antidepressants. Stephen M. Stahl. University of California at San Diego. Nancy Muntner. Illustrations. Angela Felker.
Antidepressants Stephen M. Stahl University of California at San Diego Nancy Muntner Illustrations Angela Felker Editor ii PREFACE These books are designed to be fun. All concepts are illustrated by full-color
Medication Augmentation after the Failure of SSRIs for Depression
The new england journal of medicine original article Medication Augmentation after the Failure of SSRIs for Depression Madhukar H. Trivedi, M.D., Maurizio Fava, M.D., Stephen R. Wisniewski, Ph.D., Michael
Targets of Psychopharmacological Drug Action
Targets of Psychopharmacological Drug Action (page 33 in syllabus) Stephen M. Stahl, MD, PhD Adjunct Professor, Department of Psychiatry University of California, San Diego School of Medicine Honorary
Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report
Article Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report Patrick J. McGrath, M.D. Jonathan W. Stewart, M.D. Maurizio Fava, M.D.
Patients with major depressive disorder often also suffer
Article Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D Report Maurizio Fava, M.D. A. John Rush, M.D. Jonathan E. Alpert, M.D., Ph.D. G.K. Balasubramani,
Reliable diagnosis, count of adequate antidepressant trials can suggest next steps
Web audio at CurrentPsychiatry.com Dr. Mischoulon: Clinical application of the SAFER and ATRQ ONLINE ONLY Reliable diagnosis, count of adequate antidepressant trials can suggest next steps Martin Desseilles,
The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication
(2010) 15, 856 867 & 2010 Macmillan Publishers Limited All rights reserved 1359-4184/10 www.nature.com/mp ORIGINAL ARTICLE The importance of irritability as a symptom of major depressive disorder: results
A BS TR AC T. n engl j med 356;17 april 26,
The new england journal of medicine established in 1812 april 26, 2007 vol. 356 no. 17 Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression Gary S. Sachs, M.D., Andrew A. Nierenberg,
C-SSRS/KIT version includes. C-SSRS Scoring/ Administration instructions (13pgs)
This is a Sample version of the Columbia-Suicide Severity Rating Scale (C-SSRS) KIT The full version of watermark.. the C-SSRS/KIT comes without sample The full complete C-SSRS/KIT version includes C -SSRS
Treatment of Patients With Major Depressive Disorder
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder Third Edition WORK GROUP ON MAJOR DEPRESSIVE DISORDER Alan J. Gelenberg, M.D., Chair Marlene P. Freeman, M.D. John C. Markowitz,
PSYCHOPHARMACOLOGY THURSDAY-SUNDAY, OCTOBER 22-25, Westin Copley Place 10 Huntington Ave., Boston, MA COURSE DIRECTORS:
PSYCHOPHARMACOLOGY THURSDAY-SUNDAY, OCTOBER 22-25, 2015 Westin Copley Place 10 Huntington Ave., Boston, MA COURSE DIRECTORS: Jerrold F. Rosenbaum, MD Psychiatrist-in-Chief Stanley Cobb Professor of Psychiatry
Antipsychotics and Mood Stabilizers
Antipsychotics and Mood Stabilizers The best-selling Stahl s Essential Psychopharmacology fully revised and updated throughout continues its tradition of being the preeminent source of information in its
Organizational, or Other Financial Benefit None None None None None None. None None None None None None
Comprehensive Relationships With Industry and Other Entities AHA/ACC 2017 Update of ST-Elevation Myocardial Infarction and Non ST-Elevation Myocardial Infarction Measures Committee Jneid Hani, Chair Baylor
ANXIOUS DEPRESSION. Ned H. Kalin, MD University of Wisconsin Alan F. Schatzberg, MD Stanford University
ANXIOUS DEPRESSION Ned H. Kalin, MD University of Wisconsin Alan F. Schatzberg, MD Stanford University NED H. KALIN, MD Disclosures!! Research/Grants: None!! Speakers Bureau: None!! Consultant: None!!
Brief Report. Published by John Wiley & Sons Ltd.
Bipolar Disorders 2015: 17: 212 223 Brief Report 2014 John Wiley & Sons A/S Published by John Wiley & Sons Ltd. BIPOLAR DISORDERS Medical burden in bipolar disorder: findings from the Clinical and Health
Poor quality of life and functioning in bipolar disorder
DOI 10.1186/s40345-017-0078-4 RESEARCH Open Access Poor quality of life and functioning in bipolar disorder Louisa G. Sylvia 1,2*, Rebecca E. Montana 1, Thilo Deckersbach 1,2, Michael E. Thase 3, Maurcio
Factors that distinguish college students. with depressive symptoms with and without SI.
ANNALS OF CLINICAL PSYCHIATRY 2013;25(1):41-49 RESEARCH ARTICLE Factors that distinguish college students with depressive symptoms with and without suicidal thoughts Maren Nyer, PhD Daphne J. Holt, MD,
Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia
Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia Richard Keefe, Ph.D. Duke University Medical Center Durham, North Carolina, USA
ORIGINAL RESEARCH Primary Psychiatry. 2010;17(3):44-52 ABSTRACT INTRODUCTION FOCUS POINTS
ORIGINAL RESEARCH Primary Psychiatry. 2010;17(3):44-52 D. Goodman, S.V. Faraone, L.A. Adler, B. Dirks, M. Hamdani, R. Weisler Interpreting ADHD Rating Scale Scores: Linking ADHD Rating Scale Scores and
CURRICULUM VITAE Intern in Medicine, Beth Israel Hospital, Harvard Medical School, Boston, MA
Bruce D. Kohrman, M.D. 12305 SW 69 th Place Miami, Florida 33156 Telephone: (305) 903-8678 Fax: (305) 661-1672 CURRICULUM VITAE EDUCATION 1977 - B.S. Stanford University, Stanford, CA 1982 - M.D. Case
HHS Public Access Author manuscript Mol Psychiatry. Author manuscript; available in PMC 2011 February 01.
The Importance of Irritability as a Symptom of Major Depressive Disorder: Results from the National Comorbidity Survey Replication Maurizio Fava, M.D., Irving Hwang, M.A., A. John Rush, M.D., Nancy Sampson,
A Clinical Context Report
Stroke Prevention in Atrial Fibrillation An Expert Commentary With Kenneth W. Mahaffey, MD A Clinical Context Report Stroke Prevention in Atrial Fibrillation Expert Commentary Jointly Sponsored by: and
Dunner and Fieve (1) originally coined the term
Article The Prospective Course of Rapid-Cycling Bipolar Disorder: Findings From the STEP-BD Christopher D. Schneck, M.D. David J. Miklowitz, Ph.D. Sachiko Miyahara, M.S. Mako Araga, M.S. Stephen Wisniewski,
Mood and Anxiety Disorders: The Complexities of Integrating Syndromes
Mood and Anxiety Disorders: The Complexities of Integrating Syndromes Ned Kalin, MD University of Wisconsin School of Medicine Martin B. Keller, MD Brown Medical School David R. Rubinow, MD University
Novel Approaches to Address Treatment Resistant Depression: Targeting Multiple Mechanisms of Action
AXS-05 R&D Day April 24, 2018 Novel Approaches to Address Treatment Resistant Depression: Targeting Multiple Mechanisms of Action Maurizio Fava, MD Director, Division of Clinical Research, Massachusetts
Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies
Young et al. International Journal of Bipolar Disorders 2013, 1:10 RESEARCH Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies Allan H Young 1,13*, Joseph
Title: Authors: Journal:
IMPORTANT COPYRIGHT NOTICE: This electronic article is provided to you by courtesy of Shire Australia. The document is provided for personal usage only. Further reproduction and/or distribution of the
Sleep Quality, Posttraumatic Stress, Depression, and Human Errors in Train Drivers: A Population-Based Nationwide Study in South Korea
pii: sp-00577-13 http://dx.doi.org/10.5665/sleep.4252 SLEEP QUALITY, PTSD, AND ERRORS IN TRAIN DRIVERS: POPULATION-BASED STUDY Sleep Quality, Posttraumatic Stress, Depression, and Human Errors in Train
PSYCHOPHARMACOLOGY. Westin Copley Place 10 Huntington Ave., Boston, MA. Course Directors:
40th Annual PSYCHOPHARMACOLOGY Thursday-Sunday, October 20-23, 2016 Westin Copley Place 10 Huntington Ave., Boston, MA Course Directors: Jerrold F. Rosenbaum, MD Psychiatrist-in-Chief Massachusetts General
SUNY Binghamton, B.S. Biochemistry, 5/80 SUNY Downstate Medical Center, M.D., 6/84
CURRICULUM VITAE RUSSELL D'AMBRA, M.D. July 2014 North Shore Diabetes & Endocrine Associates 3003 New Hyde Park Road Suite 201 New Hyde Park, New York 11042 516-327-0850 EDUCATION: POST-GRADUATE TRAINING:
INTRODUCTION. Neuropsychopharmacology (2008) 33, & 2008 Nature Publishing Group All rights reserved X/08 $30.00
(2008) 33, 2810 2819 & 2008 Nature Publishing Group All rights reserved 0893-133X/08 $30.00 www.neuropsychopharmacology.org Pharmacogenetic Analysis of Genes Implicated in Rodent Models of Antidepressant
ORIGINAL ARTICLE. Trial Registration: clinicaltrials.gov Identifier: NCT
ORIGINAL ARTICLE Cognitive Behavioral Analysis System of Psychotherapy and Brief Supportive Psychotherapy for Augmentation of Antidepressant Nonresponse in Chronic Depression The REVAMP Trial James H.
Supported by an unrestricted educational grant by Merck & Co.
Supported by an unrestricted educational grant by Merck & Co. TABLE OF CONTENTS Agenda & Faculty List...2 Course Description...3 Learning Objectives...3 Accreditation Statement & Credit Designation...3
Despite concerns about substance abuse comorbidity,
Benzodiazepine Use and Risk of Recurrence in Bipolar Disorder: A STEP-BD Report Roy H. Perlis, MD, MSc; Michael J. Ostacher, MD, MPH; David J. Miklowitz, PhD; Jordan W. Smoller, MD, ScD; Ellen B. Dennehy,
JABLONSKI DEBATES PSA TESTING
The JABLONSKI DEBATES PSA TESTING Getting Prostrate for the Prostate The JABLONSKI DEBATES Learning has never been this much fun (just like walking through a field littered with land mines.) The JABLONSKI
John Ansell President, John Ansell Consultancy Thame, UK
Rutgers University Monday 29 September 2014 Co Eli Lilly Bristol-Myers Squibb Novo Nordisk Pfizer GlaxoSmithKline Takeda Sanofi Novartis AstraZeneca Roche Otsuka Johnson & Johnson Otsuka Abbott Teva 1
Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression
International Journal of Neuropsychopharmacology (2009), 12, 773 782. Copyright f 2008 CINP doi:10.1017/s1461145708009735 Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar
The scope of the problem. Literature review
Past Year: Novartis Ever: Alkermes, Amylin, Behringer- Ingelheim, Biovail, Bristol-Myers Squibb, Eli Lilly, Embryon, GlaxoSmithKline, Merck, Organon, Park-Davis, Pfizer, Sanolfi-Aventis, Smith-Kline Beacham,
Key ASCO Presentations Issue 2, Ipilimumab Monotherapy for Patients with Melanoma and Brain Metastases
Key ASCO Presentations Issue 2, 2010 Ipilimumab Monotherapy for Patients with Melanoma and Brain Metastases For more visit ResearchToPractice.com/5MJCMT2010 CME INFORMATION OVERVIEW OF ACTIVITY Each year,
NIH Public Access Author Manuscript J Am Acad Child Adolesc Psychiatry. Author manuscript; available in PMC 2011 March 23.
NIH Public Access Author Manuscript Published in final edited form as: J Am Acad Child Adolesc Psychiatry. 2009 May ; 48(5): 484 500. doi:10.1097/chi.0b013e31819c23d0. The MTA at 8 Years: Prospective Follow-Up
US pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health
US pharmaceutical market: trends, issues, forecast Doug Long Vice President Industry Relations IMS Health 2006 Strategic management review The World Pharmaceutical Market All reproduction rights, quotations,
Second Opinion An Interactive Case-Based Discussion on the Management of Early and Advanced Breast Cancer
Second Opinion An Interactive Case-Based Discussion on the Management of Early and Advanced Breast Cancer Proceedings from a CME Satellite Symposium at the 30 th Annual San Antonio Breast Cancer Symposium
2014 COPYRIGHT PHYSICIANS POSTGRADUATE PRESS, INC. NOT FOR DISTRIBUTION, DISPLAY, OR COMMERCIAL PURPOSES.
Original Research Effect of Adjunctive l-methylfolate 15 mg Among Inadequate Responders to SSRIs in Depressed Patients Who Were Stratified by Biomarker Levels and Genotype: Results From a Randomized Clinical
journal of medicine The new england Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression ABSTRACT
The new england journal of medicine established in 1812 march 23, 2006 vol. 354 no. 12 Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression A. John Rush, M.D., Madhukar H.
West Virginia University School of Medicine, Morgantown, West Virginia
MARY CARROLL SHEMO, M.D., D.F.A.P.A. CURRICULUM VITAE Psychiatric Alliance of the Blue Ridge Office: (434) 984-6777 First Floor, Old Ivy Commons, 2496 Old Ivy Road, Suite 400 Fax: (434) 296-1412 22903-4895
Relationship of Mania Symptomatology to Maintenance Treatment Response with Divalproex, Lithium, or Placebo
(2005) 30, 1932 1939 & 2005 Nature Publishing Group All rights reserved 0893-133X/05 $30.00 www.neuropsychopharmacology.org Relationship of Mania Symptomatology to Maintenance Treatment Response with Divalproex,
Welcome. 14 TH Annual Scientific Meeting International Society for CNS Clinical Trials and Methodology February 2018 Washington, DC
Welcome 14 TH Annual Scientific Meeting International Society for CNS Clinical Trials and Methodology 20-22 February 2018 Washington, DC Internet code CNS2018 Mission Statement The International Society
ORIGINAL ARTICLE. Molecular Psychiatry (2015) 20, ; doi: /mp ; published online 26 August 2014
Molecular Psychiatry (2015) 20, 727 734 2015 Macmillan Publishers Limited All rights reserved 1359-4184/15 www.nature.com/mp ORIGINAL ARTICLE Prenatal antidepressant exposure is associated with risk for
DRAFT SLIDES. Michael Huss Child and Adolescent Psychiatry, Johannes Gutenberg University Mainz, Mainz, Germany
DRAFT SLIDES Separating efficacy and sedative effects of guanfacine extended release in children and adolescents with ADHD from four randomized, controlled, phase 3 clinical trials Michael Huss Child and
Research Article A Double-Blind Placebo-Controlled Trial of Maca Root as Treatment for Antidepressant-Induced Sexual Dysfunction in Women
Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2015, Article ID 949036, 9 pages http://dx.doi.org/10.1155/2015/949036 Research Article A Double-Blind Placebo-Controlled
CJASN Editorial Team Disclosures 2018
CJASN Editorial Team Disclosures 2018 Editor in Chief Rajnish Mehrotra, MD, MBBS, FASN Organization Name: University of Washington Current Employer: University of Washington, Seattle, WA Scientific Advisor/Membership:
Insomnia in Patients With Depression: A STAR*D Report
Insomnia in Patients With Depression: A STAR*D Report Prabha Sunderajan, MD, Bradley N. Gaynes, MD, MPH, Stephen R. Wisniewski, PhD, Sachiko Miyahara, PhD, Maurizio Fava, MD, Felicia Akingbala, MD, Joanne
INTRODUCTION. A growing number of controlled trials and meta-analyses (Burt et al, 2002; Holtzheimer et al, 2001; Martin et al, 2003;
(2009) 34, 522 534 & 2009 Nature Publishing Group All rights reserved 0893-133X/09 $32.00 www.neuropsychopharmacology.org Daily Left Prefrontal Repetitive Transcranial Magnetic Stimulation in the Acute
CHAPTER THREE: INDUSTRY OVERVIEW... 6 HISTORICAL PERSPECTIVE OF THE MENTAL HEALTH INDUSTRY... 6 HISTORICAL PERSPECTIVE OF THE (CONTINUED)...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR STUDY... 1 SCOPE OF STUDY... 1 METHODOLOGY AND INFORMATION SOURCES... 2 ANALYST CREDENTIALS... 2 RELATED BCC REPORTS... 2 DISCLAIMER...
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES PUBLISHED AUGUST 2016 There is growing distrust of pharma in light of several recent and dramatic
Recurrent, Robust and Scalable Patterns Underlie Human Approach and Avoidance
Recurrent, Robust and Scalable Patterns Underlie Human Approach and Avoidance Byoung Woo Kim 1,2., David N. Kennedy 3", Joseph Lehár 4", Myung Joo Lee 1,2", Anne J. Blood 1,2,5", Sang Lee 1,2", Roy H.
TABLE OF CONTENTS 1 Table of Contents 2 Introduction 3 Key Marketed Products
TABLE OF CONTENTS 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Epidemiology 2.2 Symptoms 2.3 Etiology 2.4 Pathophysiology 2.5 Co-morbidities and Complications 2.6 Classification
Quality of medicines in Portugal: a retrospective review of medicine recalls ( ) Ana Teresa Reis Bruna Berardo Rui Loureiro
Quality of medicines in Portugal: a retrospective review of medicine recalls (2005-2015) Ana Teresa Reis Bruna Berardo Rui Loureiro Introduction Human medicines Cosmetics Veterinary medicines Medical devices
Critical Pathways in Breast Cancer Treatment
Critical Pathways in Breast Cancer Treatment Faculty Jenny C Chang, MD Paul E Goss, MD, PhD Kathy D Miller, MD Lawrence N Shulman, MD Dennis J Slamon, MD, PhD Andrew Tutt, MB ChB, PhD Editor Neil Love,
Article. Jayendra Patel, M.D. Marshall R. Thomas, M.D. Mako Araga, M.S. Jodi M. Gonzalez, Ph.D. Stephen R. Wisniewski, Ph.D.
Article Intensive Psychosocial Intervention Enhances Functioning in Patients With Bipolar Depression: Results From a 9-Month Randomized Controlled Trial David J. Miklowitz, Ph.D. Michael W. Otto, Ph.D.
A structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trials
Targum et al. Annals of General Psychiatry 2013, 12:2 PRIMARY RESEARCH Open Access A structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trials Steven
Assessing the true effect of active antidepressant therapy v. placebo in major depressive disorder: use of a mixture model
The British Journal of Psychiatry (2011) 199, 501507. doi: 10.1192/bjp.bp.111.093336 Assessing the true effect of active antidepressant therapy v. placebo in major depressive disorder: use of a mixture
Key ASCO Presentations Issue 4, Effects of Zoledronic Acid on Overall Survival in Newly Diagnosed Multiple Myeloma (MM)
Key ASCO Presentations Issue 4, 2010 Effects of Zoledronic Acid on Overall Survival in Newly Diagnosed Multiple Myeloma (MM) For more visit ResearchToPractice.com/5MJCMT2010 CME INFORMATION OVERVIEW OF
Abbott Nutrition 1030 AbbVie 301 AbbVie 907 About the Nurse 207 Academy of Medical-Surgical Nurses 144 Academy of Oncology Nurse & Patient Navigators
Exhibitor Name Booth Number Abbott Nutrition 1030 AbbVie 301 AbbVie 907 About the Nurse 207 Academy of Medical-Surgical Nurses 144 Academy of Oncology Nurse & Patient Navigators 358 Accredo 947 Adako 276
Reduced Caudate and Nucleus Accumbens Response to Rewards in Unmedicated Individuals With Major Depressive Disorder
Article Reduced Caudate and Nucleus Accumbens Response to Rewards in Unmedicated Individuals With Major Depressive Disorder Diego A. Pizzagalli, Ph.D. Avram J. Holmes, A.M. Daniel G. Dillon, Ph.D. Elena
M. Lynn Crismon, Pharm.D., FCCP, BCPP
CURRICULUM VITAE M. Lynn Crismon, Pharm.D., FCCP, BCPP OFFICE ADDRESS College of Pharmacy, Suite 5.112 The University of Texas at Austin 2409 University Ave. MC#A1900 Austin, Texas 78712 Telephone: (512)
LEE S. COHEN, MD. Edmund and Carroll Carpenter Professor of Psychiatry Harvard Medical School
LEE S. COHEN, MD Director Ammon-Pinizzotto Center for Women s Mental Health Perinatal and Reproductive Psychiatry Clinical Research Program Massachusetts General Hospital Edmund and Carroll Carpenter Professor
Treatment-Resistant Depression (TRD)
Treatment-Resistant Depression (TRD) Maurizio Fava, MD Director, Division of Clinical Research of the MGH Research Institute Executive Vice Chair, MGH Department of Psychiatry Executive Director, MGH Clinical
February 22 23, Essential Tools for Treating the Patient in Pain. the American Academy of Pain Medicine.
the American Academy of Pain Medicine Essentials of pain, palm springs Essential Tools for Treating the Patient in Pain WHAT YOU NEED TO KNOW AT THE FRONT LINE OF PAIN MEDICINE February 22 23, 2012 Renaissance
Mood Stabilization and Destabilization During Acute and Continuation Phase Treatment for Bipolar I Disorder With Lamotrigine or Placebo
J Clin Psychiatry/Mood Stabilization and Destabilization During Acute and Continuation... Page 1 of 13 Mood Stabilization and Destabilization During Acute and Continuation Phase Treatment for Bipolar I
Sponsored by the Neuroscience Education Institute Additionally sponsored by the American Society for the Advancement of Pharmacotherapy
The Future of Antipsychotic Therapy (page 7 in syllabus) Stephen M. Stahl, MD, PhD Adjunct Professor, Department of Psychiatry University of California, San Diego School of Medicine Honorary Visiting Senior
Age / Sex: Presenting Problem:
William E. Bunney, Jr., MD, and Ned H. Kalin, MD Chart Review: Anxious Depression PATIENT INFO 17 / Female Age / Sex: Presenting Problem: DA is 17 y/o women who presented with intermittent symptoms of
SickKids Research Institute: List of Funders
SickKids Research Institute: List of Funders 2009-2010 Agency Funding $ Agency Funding $ 3M Pharmaceuticals 2,901 International Council on Amino Acid Science 80,800 Abbott Diagnostics 6,639 International
Phase II Study of Clofarabine for Older Patients with Treatment-Naïve AML
Phase II Study of Clofarabine for Older Patients with Treatment-Naïve AML CME INFORMATION OVERVIEW OF ACTIVITY Acute myeloid leukemia (AML) and the myelodysplastic syndromes (MDS) account for approximately
Brain Stimulation xxx (2012) 1e10. Contents lists available at SciVerse ScienceDirect. Brain Stimulation. journal homepage:
Brain Stimulation xxx (2012) 1e10 Contents lists available at SciVerse ScienceDirect Brain Stimulation journal homepage: www.brainstimjrnl.com Original Research Vagus nerve stimulation therapy randomized
Article. Reduced Caudate and Nucleus Accumbens Response to Rewards in Unmedicated Individuals With Major Depressive Disorder
Article Reduced Caudate and Nucleus Accumbens Response to Rewards in Unmedicated Individuals With Major Depressive Disorder Diego A. Pizzagalli, Ph.D. Avram J. Holmes, A.M. Daniel G. Dillon, Ph.D. Elena
Double-Blind, Placebo-Controlled Trial of Divalproex Monotherapy in the Treatment of Symptomatic Youth at High Risk for Developing Bipolar Disorder
Double-Blind, Placebo-Controlled Trial of Divalproex Monotherapy in the Treatment of Symptomatic Youth at High Risk for Developing Bipolar Disorder Robert L. Findling, M.D.; Thomas W. Frazier, Ph.D.; Eric
AHRQ Effective Health Care Program Clinical and Comparative Effectiveness Research Methods: II
AHRQ Effective Health Care Program Clinical and Comparative Effectiveness Research Methods: II June 1-2, 2009 John M. Eisenberg Building Agency for Healthcare Research and Quality AHRQ Conference Center
Treatment Resistant Depression: A Systematic Approach to Management
Treatment Resistant Depression: A Systematic Approach to Management Michael E. Thase, M.D. University of Pennsylvania School of Medicine Philadelphia Veterans Affairs Medical Center University of Pittsburgh
(Poster presented on Sunday 05 March, 08:50 08:55; 2017 AAD Meeting, Orlando, Florida, USA)
Secukinumab in Psoriasis Patients with Concurrent Psoriatic Arthritis: Patient-Reported Outcomes in the Corrona Psoriasis Registry AB Gottlieb, B Strober, 2 AW Armstrong, 3 JD Greenberg, 4,5 C Karki, 4
Welcome. 13 TH Annual Scientific Meeting International Society for CNS Clinical Trials and Methodology February 2017 Washington, DC
Welcome 13 TH Annual Scientific Meeting International Society for CNS Clinical Trials and Methodology 21-23 February 2017 Washington, DC Internet code CNS2017 Mission Statement The International Society
MITCHELL JAY RUBIN, M.D. FAAN (cell) Neurology Expert Witness Stroke tpa Emergency Neurology Telemedicine
Education University of Pennsylvania Philadelphia, Pennsylvania B. A. Summa Cum Laude 1976 Phi Beta Kappa 1977 Pi Gamma Mu (National Social Science Honor Society) 9/1977-5/1981 University of Pennsylvania
How can you improve. Talk to your patients about side effects and how long treatment will take. For personal use only
For mass reproduction, content licensing and permissions contact Dowden Health Media. Family Practice the journal of Charlotte Brown, PhD, Deena R. Battista, PhD Department of Psychiatry, of Medicine,
ORIGINAL RESEARCH. Brain Stimulation (2010) 3,
Brain Stimulation (2010) 3, 187 99 www.brainstimjrnl.com ORIGINAL RESEARCH Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression:
Healthcare Professional Information & Patient Information Leaflet (PL)
New concept for the SmPC/ Healthcare Professional Information & Patient Information Leaflet (PL) Fiona Reekie Director Global Regulatory Affairs Johnson & Johnson Pharmaceuticals Group Disclaimer The views
Financial/Commercial Relationships & Conflicts of Interest DISCLOSURES
Financial/Commercial Relationships & Conflicts of Interest DISCLOSURES All individuals able to influence or control content of any CME certified activity that will be presented were required to complete
Optimizing Care for Patients With Schizophrenia
Optimizing Care for Patients With Schizophrenia (page 217 in syllabus) Andrew J. Cutler, MD Courtesy Assistant Professor, Department of Psychiatry University of Florida CEO and Medical Director, Florida
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn
Letter Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, openlabel study J. Rosenstock 1,2,
The Pendulum of Bridging Periprocedural Anticoagulant Therapy. Alan K. Jacobson, MD Cardiology Section Loma Linda VA Medical Center Loma Linda, CA
The Pendulum of Bridging Periprocedural Anticoagulant Therapy Alan K. Jacobson, MD Cardiology Section Loma Linda VA Medical Center Loma Linda, CA Disclosures Department of Veterans Affairs Industry Relationships:
Autism Spectrum Disorder Across the Lifespan
Autism Spectrum Disorder Across the Lifespan Saturday - Sunday July 11-12, 2015 Boston Marriott Copley Place, Boston, MA Course Directors Joseph Biederman, MD Chief, Clinical and Research Programs in Pediatric
SUPPLEMENTARY DATA. Telediab Study Group :
Telediab Study Group : Guillaume Charpentier, MD, Department of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France Centre d Études et de Recherches pour l Intensification du Traitement du Diabète
ttention-deficit/hyperactivity disorder (ADHD) is one of the most common psychiatric disorders, Lisdexamfetamine in Adults With ADHD
in Adults With ADHD Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder Lenard A. Adler, M.D.; David W. Goodman, M.D.;
Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects on Remnant-like Particle Cholesterol From the MARINE and ANCHOR Studies
172 (Eicosapentaenoic Acid Ethyl Ester): Effects on Remnant-like Particle Cholesterol From the and Studies Christie M. Ballantyne, MD 1 ; Harold E. Bays, MD 2 ; Rene A. Braeckman, PhD 3 ; Sephy Philip,